List of insiders holdings for Eton Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Opaleye Management Inc. 10% Owner | 2024-10-25 16:05:24 | 0 2,770,000 | 2,770,000 | Form 4 |
BRYNJELSEN SEAN President & CEO | 2024-02-15 16:19:12 | 2,473,014 0 | 2,473,014 | Form 4 |
Krempa David Chief Business Officer | 2024-10-04 16:19:02 | 861,374 0 | 861,374 | Form 4 |
Troutman William Wilson CFO and Secretary | 2022-02-28 16:32:31 | 671,200 0 | 671,200 | Form 4 |
Gruber James R. Chief Financial Officer | 2024-02-15 16:21:05 | 374,763 0 | 374,763 | Form 4 |
RIEDEL NORBERT G Director | 2024-02-15 16:15:51 | 164,555 0 | 164,555 | Form 4 |
MAIER PAUL V Director | 2024-02-15 16:16:41 | 164,555 0 | 164,555 | Form 4 |
CASAMENTO CHARLES J Director | 2024-02-15 16:18:19 | 164,555 0 | 164,555 | Form 4 |
Adams Jennifer McKie Director | 2024-02-15 16:19:59 | 133,133 0 | 133,133 | Form 4 |
BAUM MARK L Director | 2020-03-16 16:58:11 | 27,400 0 | 27,400 | Form 4 |
HARROW HEALTH INC. 10% Owner | 2024-04-30 07:00:15 | 0 0 | 0 | Form 13D |